CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced the selection of eight new U.S. non-profit organizations as grant recipients, as part of its $14.6 million commitment to its FY2023 U.S. Corporate Social Responsibility (CSR) program. To create greater impact and foster equity in under-resourced communities, the company is focusing its philanthropic efforts on the two areas of Food is Health and Building STEM (Science, Technology, Engineering and Math) Foundations and providing larger, multi-year grants to select nonprofits.

马萨诸塞州剑桥市。-（商业新闻短讯）--武田（东京证交所：4502/纽约证交所：TAK）今天宣布选择八家新的美国非营利组织作为赠款接受者，作为其对2023财年美国企业社会责任（CSR）计划1460万美元承诺的一部分。为了在资源不足的社区产生更大的影响和促进公平，该公司将其慈善努力集中在食品健康和建设STEM（科学、技术、工程和数学）基金会这两个领域，并为选定的非营利组织提供更大的多年赠款。

Combined with previous investments since 2021, Takeda’s total contribution to these initiatives now amounts to $54.1 million..

加上自2021年以来的先前投资，武田对这些举措的总贡献现已达到5410万美元。。

“By focusing our efforts on Food is Health and Building STEM Foundations, we are evolving our program to address two areas of significant need that will help build up communities and narrow disparities that can prevent people from realizing their full potential,” said Julie Kim, president of Takeda’s U.S.

武田美国公司总裁朱莉·金（JulieKim）表示：“通过将我们的工作重点放在食品即健康和建立STEM基础上，我们正在发展我们的计划，以解决两个重要需求领域，这将有助于建立社区和缩小差距，从而阻止人们充分发挥其潜力。”。

Business Unit and U.S. Country Head. “We are excited to continue this important work with our new partners, collectively striving to drive long-term impact within our local communities and more broadly.”.

业务部门和美国国家负责人。“我们很高兴与我们的新合作伙伴继续这项重要工作，共同努力在当地社区和更广泛的范围内产生长期影响。”。

Takeda reviews grant applications for its U.S. CSR program twice a year. The company partners with local and national organizations that align with its philanthropic focus areas, actively listening and valuing their insights and expertise to understand the areas of greatest need within communities. By leveraging this collaborative approach, Takeda provides support to address these critical needs and make a positive impact on people's lives..

武田每年两次审查其美国企业社会责任计划的拨款申请。该公司与符合其慈善重点领域的地方和国家组织合作，积极倾听并重视他们的见解和专业知识，以了解社区内最需要的领域。通过利用这种协作方法，武田为解决这些关键需求提供支持，并对人们的生活产生积极影响。。

Takeda’s FY2023 U.S. CSR Grantees

武田2023财年美国CSR受赠方

Strengthening the Connection Between Food and Health for vulnerable and underserved communities around the country:

加强全国弱势和服务不足社区的食品与健康之间的联系：

Community Servings – Medically tailored nutrition program and advancement of policies that prioritize food’s role in public health

社区服务-医学定制的营养计划和优先考虑食品在公共卫生中的作用的政策的推进

West End House – Health, nutrition, food access and education programs

West End House–健康、营养、食物获取和教育计划

Open Hand Atlanta – Medically tailored meals for socially vulnerable individuals

Open Hand Atlanta–为社会弱势群体量身定制的医学套餐

Project Angel Food – Home delivered medically tailored meals program for critically ill people

天使食品项目-为危重病人提供家庭定制的医学餐计划

Northern Illinois Food Bank – Build healthy communities program

北伊利诺伊州食品银行-建立健康社区计划

Greater Chicago Food Depository – Prepared meals program

大芝加哥食品储藏室——备餐计划

Building STEM Foundations to promote educational equity from kindergarten through college:

建立STEM基金会，促进从幼儿园到大学的教育公平：

Project Scientist – Phased national expansion of STEAM programming and gender- and race-equitable teacher training through the Project Scientist Teaching Institute

项目科学家——通过项目科学家教学研究所，分阶段在全国范围内扩大STEAM编程以及性别和种族平等的教师培训

Thrive Scholars – STEM pathways (Technology, Engineering and Life Sciences) support and Boston expansion

Thrive Scholars–STEM路径（技术、工程和生命科学）支持和波士顿扩张

Takeda recently published Caring for Tomorrow: 2023 U.S. Community Impact Report, an annual report that provides a comprehensive overview of the initiatives and partnerships that are making a difference in the lives of communities across the country. Further details on the company’s U.S. CSR, health equity and diversity, equity and inclusion programs can be found in the report..

武田最近出版了《关心明天：2023年美国社区影响报告》，该年度报告全面概述了正在改变全国社区生活的举措和伙伴关系。有关该公司美国企业社会责任、健康公平与多样性、公平与包容计划的更多详细信息，请参见报告。。

Learn more about Takeda’s U.S. CSR Program and its philanthropic strategy here. You can find more details about Takeda’s Global CSR Program here.

在此了解更多有关武田美国企业社会责任计划及其慈善战略的信息。您可以在这里找到有关武田全球CSR计划的更多详细信息。

About Takeda

关于武田

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines.

武田致力于为人们创造更好的健康，为世界创造更美好的未来。我们的目标是在我们的核心治疗和业务领域发现并提供改变生命的治疗方法，包括胃肠道和炎症、罕见疾病、血浆衍生疗法、肿瘤学、神经科学和疫苗。

Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet.

与我们的合作伙伴一起，我们的目标是通过我们动态多样的渠道改善患者体验，并推进治疗选择的新前沿。作为总部位于日本的领先的基于价值观、研发驱动的生物制药公司，我们以对患者、人民和地球的承诺为指导。

Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com..

我们在大约80个国家和地区的员工是由我们的目标驱动的，并以两个多世纪以来定义我们的价值观为基础。有关更多信息，请访问www.takeda.com。。

Forward-Looking Statements

前瞻性声明

This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could” “anticipates”, “estimates”, “projects” or similar expressions or the negative thereof.

本新闻稿和与本新闻稿相关的任何材料可能包含有关武田未来业务、未来地位和经营成果的前瞻性声明、信念或意见，包括武田的估计、预测、目标和计划。不受限制，前瞻性陈述通常包括“目标”、“计划”、“相信”、“希望”、“继续”、“期望”、“目标”、“意图”、“确保”、“将”、“可能”、“应该”、“将”、“可能”、“预期”、“估计”、“项目”或类似表达或其负面含义。

These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States; competitive pressures and developments; changes to applicable laws and regulations, including global health care reforms; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic, on Takeda and its customers and suppliers, including foreign governments in countries in which Takeda operates, or on other facets of its business; the timing and impact of post-merger integration efforts with acquired companies; the ability to dive.

这些前瞻性陈述基于对许多重要因素的假设，包括以下因素，这些因素可能导致实际结果与前瞻性陈述中明示或暗示的结果存在重大差异：围绕武田全球业务的经济情况，包括日本和美国的一般经济状况；竞争压力和发展；适用法律法规的变更，包括全球医疗保健改革；新产品开发固有的挑战，包括临床成功的不确定性以及监管机构的决策及其时间安排；新产品和现有产品商业成功的不确定性；制造困难或延误；利率和货币汇率波动；关于上市产品或候选产品的安全性或有效性的索赔或担忧；健康危机（如新型冠状病毒大流行）对武田及其客户和供应商（包括武田经营所在国的外国政府）或其业务的其他方面的影响；与被收购公司进行并购后整合的时机和影响；潜水的能力。